Pharmaceutical Executive
January 30, 2019
Features
38
12
Financial leaders from clinical-stage biopharma gather to discuss the critical role of finance and accounting (F&A) in supporting and sustaining the science at the forefront of engagement with investors.
December 10, 2018
Columns
38
12
The Commission’s gestures toward enacting formal standards to digitize health records are masking wider policy gaps.
December 10, 2018
Columns
38
12
Almost a year and a half later, key understandings have emerged to help companies better combat future data-breach attempts.
December 10, 2018
Features
38
12
While the increasing importance of real-world evidence (RWE) is widely acknowledged, the dramatic shift required by pharma to embed meaningful and holistic benefits from this capability is still a work in progress.
December 10, 2018
Features
38
12
Sonalee Agarwal, head of value and evidence strategy for Alnylam, talks with Pharm Exec about the role of real-world evidence in the rare and ultra-rare disease space.
December 10, 2018
From the Editor
38
12
In pharma, there may be hope that companies' and the industry's ability to adapt to change may finally be catching up to the pace of new and intelligent uses of technology and clinical data.
December 08, 2018
Features
38
12
There is still no structured method of assessing pricing and access risk for drug manufacturers. Presented here is a straightforward measure for integrating pricing and access risk into portfolio planning and decision-making.
December 01, 2018
Columns
38
12
Objective considerations when gauging investment.
December 01, 2018
Issue PDF
38
12
Click the title above to open the Pharmaceutical December 2018 issue in an interactive PDF format.
December 01, 2018
Special Sponsored Section
38
12
With a reputation as a reliable, if somewhat unspectacular, marketplace, Malaysia has long appealed to life science investors lured in by the prospect of generating consistent returns.
November 10, 2018
Columns
38
12
Efforts intensify to bring outlays more in line with global trends.